156 related articles for article (PubMed ID: 15326250)
21. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.
RMC Trial Group
Lancet Neurol; 2009 Feb; 8(2):158-64. PubMed ID: 19136303
[TBL] [Abstract][Full Text] [Related]
22. Intravenous immunoglobulin response in treatment-naïve chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; Hahn AF; Vermeulen M; Venance SL; van Doorn PA
J Neurol Neurosurg Psychiatry; 2015 Dec; 86(12):1331-6. PubMed ID: 25515502
[TBL] [Abstract][Full Text] [Related]
23. Mycophenolate mofetil for treatment of idiopathic nephrotic syndrome in children.
Nickavar A; Safarzadeh AE; Sotoudeh K; Otukesh H; Hooman N
Iran J Kidney Dis; 2012 Sep; 6(5):346-9. PubMed ID: 22976259
[TBL] [Abstract][Full Text] [Related]
24. CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapies.
Le Cann M; Bouhour F; Viala K; Simon L; Tard C; Rossi C; Morel G; Lagrange E; Magy L; Créange A; Michaud M; Franques J; Echaniz-Laguna A; Antoine JC; Baron M; Arnulf B; Puma A; Delmont E; Maisonobe T; Leblond V; Roos-Weil D
Blood; 2020 Nov; 136(21):2428-2436. PubMed ID: 32959046
[TBL] [Abstract][Full Text] [Related]
25. Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia.
Miura Y; Devaux JJ; Fukami Y; Manso C; Belghazi M; Wong AH; Yuki N;
Brain; 2015 Jun; 138(Pt 6):1484-91. PubMed ID: 25808373
[TBL] [Abstract][Full Text] [Related]
26. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis.
Kolomeyer AM; Ragam A; Shah K; Jachens AW; Tu Y; Chu DS
Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
28. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
[TBL] [Abstract][Full Text] [Related]
29. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
[TBL] [Abstract][Full Text] [Related]
30. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial.
Gorson KC; Natarajan N; Ropper AH; Weinstein R
Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492
[TBL] [Abstract][Full Text] [Related]
31. A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy.
Comi G; Roveri L; Swan A; Willison H; Bojar M; Illa I; Karageorgiou C; Nobile-Orazio E; van den Bergh P; Swan T; Hughes R; Aubry J; Baumann N; Hadden R; Lunn M; Knapp M; Léger JM; Bouche P; Mazanec R; Meucci N; van der Meché F; Toyka K;
J Neurol; 2002 Oct; 249(10):1370-7. PubMed ID: 12382151
[TBL] [Abstract][Full Text] [Related]
32. [Modern aspects of diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy in children].
Kozyreva AA; Bembeeva RT; Druzhinina ES; Zavadenko NN; Kolpakchi LM; Pilia SV
Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(2):58-68. PubMed ID: 38465811
[TBL] [Abstract][Full Text] [Related]
33. Mycophenolate mofetil therapy for inflammatory eye disease.
Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
[TBL] [Abstract][Full Text] [Related]
34. Treatment of immune-mediated, dysimmune neuropathies.
Finsterer J
Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
[TBL] [Abstract][Full Text] [Related]
35. Severe Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy.
Seino Y; Nakamura T; Hirohata M; Kawarabayashi T; Okushima T; Shoji M
Intern Med; 2019 Mar; 58(6):855-859. PubMed ID: 30449785
[TBL] [Abstract][Full Text] [Related]
36. Therapy of rheumatoid arthritis with mycophenolate mofetil.
Goldblum R
Clin Exp Rheumatol; 1993; 11 Suppl 8():S117-9. PubMed ID: 8324935
[TBL] [Abstract][Full Text] [Related]
37. Mycophenolate mofetil therapy for severe immune thrombocytopenia.
Taylor A; Neave L; Solanki S; Westwood JP; Terrinonive I; McGuckin S; Kothari J; Cooper N; Stasi R; Scully M
Br J Haematol; 2015 Nov; 171(4):625-30. PubMed ID: 26250874
[TBL] [Abstract][Full Text] [Related]
38. Mycophenolate mofetil as a treatment for urticarial dermatitis.
Chaptini C; Sidhu S
Australas J Dermatol; 2014 Nov; 55(4):275-8. PubMed ID: 25178716
[TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
40. High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
Nobile-Orazio E; Bersano A
Neurol Sci; 2002 Apr; 23 Suppl 1():S25-32. PubMed ID: 12032584
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
